Last reviewed · How we verify
Ketorolac Injection
Ketorolac Injection is a Small molecule drug developed by Massachusetts General Hospital. It is currently FDA-approved. Also known as: Toradol, Aculare, Allergan.
At a glance
| Generic name | Ketorolac Injection |
|---|---|
| Also known as | Toradol, Aculare, Allergan |
| Sponsor | Massachusetts General Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Efficiency of Periarticular Multimodal Drug Injection in Pain Management Following Primary Unilateral TKA (NA)
- Comparison of Pain Reduction in Painful Chronic Wounds With and Without Fat Grafting (NA)
- Post-Operative Pain Relief: Zynrelef or Periarticular Injections in RATKA (PHASE4)
- Comparison Of Clinical Outcomes of Intraperitoneal Bupivacaine Instillation Versus Placebo as Preemptive Analgesia in Patients Undergoing Open Appendectomy (PHASE1)
- Low-Dose Short-Term Ketorolac to Reduce Chronic Opioid Use in Orthopaedic Polytrauma Patients (PHASE4)
- NSAID Injection Versus Corticosteroid Injection for Basilar Thumb Arthritis (PHASE3)
- Optimizing Pain Treatment in Children On Mechanical Ventilation (PHASE3)
- Ketorolac Applied by Continuous IV Infusion for Treatment of Moderately Severe Postoperative Pain Following Bunionectomy (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ketorolac Injection CI brief — competitive landscape report
- Ketorolac Injection updates RSS · CI watch RSS
- Massachusetts General Hospital portfolio CI
Frequently asked questions about Ketorolac Injection
What is Ketorolac Injection?
Ketorolac Injection is a Small molecule drug developed by Massachusetts General Hospital.
Who makes Ketorolac Injection?
Ketorolac Injection is developed and marketed by Massachusetts General Hospital (see full Massachusetts General Hospital pipeline at /company/massachusetts-general-hospital).
Is Ketorolac Injection also known as anything else?
Ketorolac Injection is also known as Toradol, Aculare, Allergan.
What development phase is Ketorolac Injection in?
Ketorolac Injection is FDA-approved (marketed).
Related
- Manufacturer: Massachusetts General Hospital — full pipeline
- Also known as: Toradol, Aculare, Allergan
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing